The new technology assessment

New England Journal of Medicine

Volumn 323, Issue 10, 1990, Pages 673-677

  Fuchs, Victor R ^a   Garber, Alan M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; SHORT SURVEY; TECHNOLOGY;

EID: 0024988344     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199009063231011     Document Type: Editorial

References (31)

1. Major RH. A history of medicine. Springfield, III.: Charles C Thomas, 1954.
2. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018–22.
3. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978; 299: 1397–401.
4. Office of Technology Assessment, U.S. Congress. The implications of cost-effectiveness analysis of medical technology: background paper. Washington, D.C.: Government Printing Office, 1980.
5. Weinstein MC, Stason WB. Hypertension: a policy perspective. Cambridge. Mass.: Harvard University Press, 1976.
6. Bunker JP, Barnes BA, Mosteller F. Costs, risks, and benefits of surgery. New York: Oxford University Press, 1977.
7. Roper WL, Winkenwerder W, Hackbarth GM, Krakauer H. Effectiveness in health care: an initiative to evaluate and improve medical practice. N Engl J Med 1988; 319: 1197–202.
8. Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention, Institute of Medicine. Assessing medical technologies. Washington, D.C.: National Academy Press, 1985.
9. Lemna WK, Feldman GL, Kerem B-s, et al. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med 1990; 322: 291–6.
10. Kerem B-s, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073–80.
11. Eddy DM. Screening for cancer: theory, analysis, and design. Englewood Cliffs, N.J.: Prentice-Hall, 1980.
12. Eddy. The confidence profile method: a Bayesian method for assessing health technologies. Oper Res 1989; 37: 210–28.
13. Shachter RD, Eddy DM, Hasselblad V. An influence diagram approach to medical technology assessment. In: Oliver RM, Smith JQ, eds. Influence diagrams, belief nets and decision analysis. London: Wiley, 1990.
14. Phelps CE, Mushlin AI. Focusing technology assessment using medical decision theory. Med Decis Making 1988; 8: 279–89.
15. Schwartz JS, Ball JR, Moser RH. Safety, efficacy, and effectiveness of clinical practices: a new initiative. Ann Intern Med 1982; 96: 246–7.
16. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450–5.
17. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224–33.
18. Littenberg B, Garber AM, Sox HC Jr. Screening for hypertension. Ann Intern Med 1990; 112: 192–202.
19. Weinstein MC. Cost-effective priorities for cancer prevention. Science 1983; 221: 17–23.
20. Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 1990; 323: 621–6.
21. Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JW. Watchful waiting vs. immediate transurethral resection for symptomatic prostatism: the importance of patients' preferences. JAMA 1988; 259: 3010–7.
22. Banta HD, Thacker SB. The case for reassessment of health care technology: once is not enough. JAMA 1990; 264: 235–40.
23. Relman AS. Assessment and accountability: the third revolution in medical care. N Engl J Med 1988; 319: 1220–2.
24. Russell LB. Some of the tough decisions required by a national health plan. Science 1989; 246: 892–6.
25. Fuchs VR. Health care and the United States economic system: an essay in abnormal physiology. Milbank Mem Fund Q 1972; 50: 211–37.
26. Sechrest L, Perrin E, Bunker J, eds. Research methodology: strengthening causal interpretations of nonexperimental data. Washington, D.C.: Government Printing Office, 1990. (DHHS publication no. (PHS) 90–3454.)
27. Moses LE, Brown BW Jr. Experiences with evaluating the safety and efficacy of medical technologies. Annu Rev Public Health 1984; 5: 267–92.
28. Wennberg J, Gittelsohn A. Small area variations in health care delivery: a population-based health information system can guide planning and regulatory decision-making. Science 1973; 182: 1102–8.
29. Leape LL, Park RE, Solomon DH, Chassin MR, Kosecoff J, Brook RH. Does inappropriate use explain small-area variations in the use of health care services? JAMA 1990; 263: 669–72.
30. Chassin MR, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987; 258: 2533–7.
31. Lomas J, Anderson GM, Domnick-Pierre K, VaydaE, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321: 1306–11.